about
Association of Soluble Interleukin-2 Receptor and C-Reactive Protein with the Efficacy of Bendamustine Salvage Treatment for Indolent Lymphomas and Mantle Cell Lymphoma.A high-throughput fluorescence polarization assay for discovering inhibitors targeting the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3)
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Inhibition of STAT3 by Anticancer Drug Bendamustine
@ast
Inhibition of STAT3 by Anticancer Drug Bendamustine
@en
type
label
Inhibition of STAT3 by Anticancer Drug Bendamustine
@ast
Inhibition of STAT3 by Anticancer Drug Bendamustine
@en
prefLabel
Inhibition of STAT3 by Anticancer Drug Bendamustine
@ast
Inhibition of STAT3 by Anticancer Drug Bendamustine
@en
P2093
P2860
P1433
P1476
Inhibition of STAT3 by Anticancer Drug Bendamustine
@en
P2093
Akira Asai
Daisuke Muraoka
Kazunori Iwamoto
Kenji Matsuno
Kyoko Taguchi
Naohisa Ogo
Yukie Inoue
Yutaka Uehara
P2860
P304
P356
10.1371/JOURNAL.PONE.0170709
P407
P577
2017-01-26T00:00:00Z